Francesco Passamonti, MD - Myelofibrosis Under the Microscope: Exploring p53 Dysregulation as a Potential Therapeutic Target

Visit https://www.peervoice.com/FCE860 to view the entire programme with slides. After completing “Francesco Passamonti, MD - Myelofibrosis Under the Microscope: Exploring p53 Dysregulation as a Potential Therapeutic Target”, participants will be able to: Recall the cellular role of p53 in regulating apoptosis, and how this is disrupted in patients with myelofibrosis; and Assess the clinical significance of trial data evaluating the safety and efficacy of MDM2 inhibition (as monotherapy or in combination with other agents) in the therapeutic management of patients with TP53-wt myelofibrosis.

Listen